Ryvu Therapeutics (Poland) Probability of Future Stock Price Finishing Under 52.13

RVU Stock   45.30  1.15  2.48%   
Ryvu Therapeutics' future price is the expected price of Ryvu Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ryvu Therapeutics SA performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
  
Please specify Ryvu Therapeutics' target price for which you would like Ryvu Therapeutics odds to be computed.

Ryvu Therapeutics Target Price Odds to finish below 52.13

The tendency of Ryvu Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under  52.13  after 90 days
 45.30 90 days 52.13 
about 71.77
Based on a normal probability distribution, the odds of Ryvu Therapeutics to stay under  52.13  after 90 days from now is about 71.77 (This Ryvu Therapeutics SA probability density function shows the probability of Ryvu Stock to fall within a particular range of prices over 90 days) . Probability of Ryvu Therapeutics price to stay between its current price of  45.30  and  52.13  at the end of the 90-day period is about 58.47 .
Assuming the 90 days trading horizon Ryvu Therapeutics SA has a beta of -0.39 indicating as returns on the benchmark increase, returns on holding Ryvu Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Ryvu Therapeutics SA is likely to outperform the market. Additionally Ryvu Therapeutics SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Ryvu Therapeutics Price Density   
       Price  

Predictive Modules for Ryvu Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ryvu Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ryvu Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Ryvu Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ryvu Therapeutics is not an exception. The market had few large corrections towards the Ryvu Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ryvu Therapeutics SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ryvu Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.2
β
Beta against Dow Jones-0.39
σ
Overall volatility
4.05
Ir
Information ratio -0.13

Ryvu Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ryvu Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ryvu Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ryvu Therapeutics generated a negative expected return over the last 90 days

Ryvu Therapeutics Technical Analysis

Ryvu Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Ryvu Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ryvu Therapeutics SA. In general, you should focus on analyzing Ryvu Stock price patterns and their correlations with different microeconomic environments and drivers.

Ryvu Therapeutics Predictive Forecast Models

Ryvu Therapeutics' time-series forecasting models is one of many Ryvu Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ryvu Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Ryvu Therapeutics

Checking the ongoing alerts about Ryvu Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ryvu Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ryvu Therapeutics generated a negative expected return over the last 90 days

Additional Tools for Ryvu Stock Analysis

When running Ryvu Therapeutics' price analysis, check to measure Ryvu Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryvu Therapeutics is operating at the current time. Most of Ryvu Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ryvu Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryvu Therapeutics' price. Additionally, you may evaluate how the addition of Ryvu Therapeutics to your portfolios can decrease your overall portfolio volatility.